Evidence map›Paper›PMID 26834154›Full record

ArticleThe Journal of experimental medicine2016

RAG-mediated DNA double-strand breaks activate a cell type-specific checkpoint to inhibit pre-B cell receptor signals.

Jeffrey J Bednarski, Ruchi Pandey, Emily Schulte, Lynn S White, Bo-Ruei Chen, Gabriel J Sandoval, Masako Kohyama, Malay Haldar, Andrew Nickless, Amanda Trott and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Nemo-Dependent, ATM-Mediated Signals from RAG DNA Breaks atJournal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  12. Assessing DNA Damage Responses Using B Lymphocyte Cultures.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Jeffrey J BednarskiDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110.
Ruchi PandeyDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110.
Emily SchulteDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110.
Lynn S WhiteDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110.
Bo-Ruei ChenDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110.
Gabriel J SandovalDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110.
Masako KohyamaDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110.
Malay HaldarDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110.
Andrew NicklessDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110.
Amanda TrottDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110.
Genhong ChengDepartment of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, CA 90095.
Kenneth M MurphyDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110.
Craig H BassingDivision of Cancer Pathobiology, Department of Pathology and Laboratory Medicine, Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA 19104.
Jacqueline E PaytonDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110.
Barry P SleckmanDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110 bas2022@med.cornell.edu.
Washington University in St. Louis · USChildren's Hospital of Philadelphia · USUniversity of California, Los Angeles · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
THE V(D)J RECOMBINATION REACTION AND ITS IMPACT ON LYMPHOCYTE DEVELOPMENTR01AI047829 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI SLECKMAN, BARRY P · 2000 to 2021
$7.0M
ATM FUNCTION DURING V(D)J RECOMBINATIONR01AI074953 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI SLECKMAN, BARRY P · 2009 to 2023
$5.9M
MOLECULAR ONCOLOGY TRAINING GRANTT32CA113275 · NCI · WASHINGTON UNIVERSITY · PI Matthew J Walter · 2006 to 2026
$5.7M
Training Program in Development HematologyT32HD007499 · NICHD · WASHINGTON UNIVERSITY · PI RUBIN, JOSHUA B · 1999 to 2019
$2.3M
DNA Double Strand Break Mediated Feedback Inhibition of V(D)J RecombinationR01AI112621 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI BASSING, CRAIG H · 2015 to 2019
$1.9M
ACTIVATION OF CELLULAR SIGNALING PATHWAYS BY DNA DOUBLE STRAND BREAKSR01CA136470 · NCI · WASHINGTON UNIVERSITY · PI BASSING, CRAIG H, SLECKMAN, BARRY P · 2009 to 2013
$1.6M
METABOLIC CONTROL OF TISSUE SPECIFIC MACROPHAGE DIFFERENTIATIONK08AI106953 · NIAID · WASHINGTON UNIVERSITY · PI HALDAR, MALAY · 2013 to 2017
$857k
INTEGRATION OF DNA DAMAGE RESPONSES WITH IMMUNE DEVELOPMENT AND FUNCTIONK08AI102946 · NIAID · WASHINGTON UNIVERSITY · PI BEDNARSKI, JEFFREY J · 2012 to 2016
$634k
NCATS NIH HHS UL1 TR000448NCI NIH HHS CA136470NCI NIH HHS P30 CA091842NCI NIH HHS R01 CA136470NCI NIH HHS T32 CA113275NIAID NIH HHS AI074953NIAID NIH HHS AI47829NIAID NIH HHS K08 AI102946NIAID NIH HHS K08AI102946-01NIAID NIH HHS K08 AI106953NIAID NIH HHS K08AI106953NIAID NIH HHS R01 AI047829NIAID NIH HHS R01 AI074953NIAID NIH HHS R01 AI112621NIAID NIH HHS R01AI112621NICHD NIH HHS T32 HD007499
6 · The paper itself

Abstract

DNA double-strand breaks (DSBs) activate a canonical DNA damage response, including highly conserved cell cycle checkpoint pathways that prevent cells with DSBs from progressing through the cell cycle. In developing B cells, pre-B cell receptor (pre-BCR) signals initiate immunoglobulin light (Igl) chain gene assembly, leading to RAG-mediated DNA DSBs. The pre-BCR also promotes cell cycle entry, which could cause aberrant DSB repair and genome instability in pre-B cells. Here, we show that RAG DSBs inhibit pre-BCR signals through the ATM- and NF-κB2-dependent induction of SPIC, a hematopoietic-specific transcriptional repressor. SPIC inhibits expression of the SYK tyrosine kinase and BLNK adaptor, resulting in suppression of pre-BCR signaling. This regulatory circuit prevents the pre-BCR from inducing additional Igl chain gene rearrangements and driving pre-B cells with RAG DSBs into cycle. We propose that pre-B cells toggle between pre-BCR signals and a RAG DSB-dependent checkpoint to maintain genome stability while iteratively assembling Igl chain genes.

Indexed as

DNA Breaks, Double-StrandedAdaptor Proteins, Signal TransducingAnimalsAtaxia Telangiectasia Mutated ProteinsCell Cycle CheckpointsCell ProliferationDNA-Binding ProteinsGene Rearrangement, B-Lymphocyte, Light ChainHomeodomain ProteinsIntracellular Signaling Peptides and ProteinsMiceMice, KnockoutMice, TransgenicNF-kappaB-Inducing KinaseNF-kappa B p52 SubunitPre-B Cell ReceptorsAdaptor Proteins, Signal TransducingAtaxia Telangiectasia Mutated ProteinsAtm protein, mouseB cell linker proteinDNA-Binding ProteinsHomeodomain ProteinsIntracellular Signaling Peptides and ProteinsNF-kappaB-Inducing KinaseNF-kappa B p52 SubunitNfkb2 protein, mousePre-B Cell ReceptorsProtein Serine-Threonine KinasesProtein-Tyrosine KinasesProto-Oncogene ProteinsProto-Oncogene Protein Spi-1RAG-1 proteinSpic protein, mouseSyk KinaseSyk protein, mouseTrans-Activators

Identifiers

PMID26834154
PMCPMC4749927
OpenAlexW2267033810

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.